Cargando…

Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis

BACKGROUND: Novel biomarkers are of particular interest for predicting cancer prognosis. This study aimed to explore the associations between enhancer of zeste homolog 2 (EZH2) and patient survival in various cancers. METHODS: Relevant literature was retrieved from PubMed and Web of Science database...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shuling, Huang, Lixia, Sun, Kaiyu, Wu, Dexi, Li, Minrui, Li, Manying, Zhong, Bihui, Chen, Minhu, Zhang, Shenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431777/ https://www.ncbi.nlm.nih.gov/pubmed/25974088 http://dx.doi.org/10.1371/journal.pone.0125480

Ejemplares similares

Long Noncoding RNA HOTAIR as an Independent Prognostic Marker in Cancer: A Meta-Analysis
por: Zhang, Shenghong, et al.
Publicado: (2014)

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
por: Ho, Thai Huu, et al.
Publicado: (2017)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
por: Wagener, Nina, et al.
Publicado: (2010)

Patients with Gastric Polyps need Colonoscopy Screening at Younger Age: A Large Prospective Cross-Sectional Study in China
por: Zhang, Shenghong, et al.
Publicado: (2019)

Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014)

Pediatric Colonoscopy in South China: A 12-Year Experience in a Tertiary Center
por: Lei, Pingguang, et al.
Publicado: (2014)

Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma
por: Zeng, Jing, et al.
Publicado: (2022)

Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
por: Hou, Tsung-Yun, et al.
Publicado: (2017)

Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
por: Nakagawa, Makoto, et al.
Publicado: (2018)

Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis
por: Huang, Xinyue, et al.
Publicado: (2020)

Targeting enhancer of zeste homolog 2 protects against acute kidney injury
por: Zhou, X., et al.
Publicado: (2018)

Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis
por: Yu, Qiao, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells
por: Ma, Huarui, et al.
Publicado: (2019)

Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes
por: WANG, HUALI, et al.
Publicado: (2015)

Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
por: Lv, Yang-Fan, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
por: Sun, Si, et al.
Publicado: (2018)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
por: Kang, Yuanyuan, et al.
Publicado: (2021)

Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023)

Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients
por: Peng, Wei, et al.
Publicado: (2022)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2017)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2021)

Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
por: ZHOU, MIN, et al.
Publicado: (2014)

Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
por: Ciarapica, Roberta, et al.
Publicado: (2011)

Correction: Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
por: Dahlby, Tina, et al.
Publicado: (2020)

Effects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer
por: Yetişir, Abdullah Evren, et al.
Publicado: (2023)

Novel Natural Inhibitors Targeting Enhancer of Zeste Homolog 2: A Comprehensive Structural Biology Research
por: Li, Weihang, et al.
Publicado: (2021)

Differential expression of microRNA, miR-150 and enhancer of zeste homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue
por: Hapugaswatta, Harsha, et al.
Publicado: (2020)

Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells
por: Yao, Yizhou, et al.
Publicado: (2016)

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
por: Hayashi, Satoshi, et al.
Publicado: (2011)

Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4
por: Lu, H, et al.
Publicado: (2013)

Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis
por: Cheng, Tianci, et al.
Publicado: (2018)

Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer
por: Shi, Bin, et al.
Publicado: (2019)

Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis
por: Bremer, Sebastian C. B., et al.
Publicado: (2022)

Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status
por: Bi, Huan, et al.
Publicado: (2017)

Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis
por: Lv, Yun-Cheng, et al.
Publicado: (2016)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation
por: Xiaoling, Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3m1bijtcbo2r2a7qck5vvet61v